학술논문
PND55 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Primary Progressive Multiple Sclerosis
Document Type
Abstract
Author
Source
In Value in Health December 2020 23 Supplement 2:S632-S633
Subject
Language
ISSN
1098-3015